Thomas L. Rihn, PharmD Senior Vice President and Chief Clinical Officer University Pharmacotherapy Associates, LLC Associate Professor of Clinical Pharmacy Duquesne University School of Pharmacy Pittsburgh, Pennsylvania Dr. Rihn is Senior Vice President and Chief Clinical Officer of University Pharmacotherapy Associates (UPA), an ACPE-accredited corporate entity founded in 1989 dedicated to excellence in national pharmaceutical education systems, clinical advisory panels, pharmaceutical industry strategic consulting, disease management, and expert pharmaceutical litigation evaluation. Dr. Rihn is an Associate Professor of Clinical Pharmacy at the Duquesne University School of Pharmacy where he is coursemaster for the integrated biomedical science/therapeutics curriculum. He also has an adjunct faculty appointment at the University of Pittsburgh School of Pharmacy. Dr. Rihn also has nearly 20 years of experience as a clinical pharmacy specialist in cardiovascular (CV)/critical care (CC) medicine in the Pittsburgh Mercy Health System. He has extensive practice and research involvement in CV/CC disease management and critical pathways, thromboembology, medication use evaluation, pharmacoeconomics and pharmacokinetics. His scholarly interests include managed pharmaceutical care as well as pharmacoeconomics research in CV/CC medicine. Dr. Rihn received his Bachelors of Science in Pharmacy and Doctor of Pharmacy degree from Duquesne University. He has also completed an ASHP-accredited pharmacy residency. He has developed nationally recognized education programs on the pharmacotherapy of acute myocardial infarction, acute coronary syndromes, thromboembolic disease, sepsis, and stroke. He has published a number of scientific papers and presented numerous invited lectures.